tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

JW (Cayman) Therapeutics Co. Ltd. (2126) Revenue

Compare
1 Followers

JW (Cayman) Therapeutics Co. Ltd. Revenue

JW (Cayman) Therapeutics Co. Ltd. had a revenue of 106.35M in the quarter ending Jun 30, 2025, with 48.94%. This bring the company's revenue in the last twelve months to 177.75M, Decreased 12.34%. In the fiscal year ending Dec 31, 2024, JW (Cayman) Therapeutics Co. Ltd. had annual revenue of 158.22M with -8.99% growth.
Revenue (ttm)
177.75M
Revenue Growth
2.45%
P/S Ratio
7.05
Revenue/Employee
HK$563,053
Employees
281
Market Cap
HK$1.12B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
158.22M-15.64M+91.01%
Dec 31, 2023
173.86M28.15M+119.32%
Dec 31, 2022
145.70M114.91M+473.10%
Dec 31, 2021
30.80M-3,079,700,000.00%
Dec 31, 2020
-5.48M
Dec 31, 2019
5.48M5.27M+2,550.24%
Dec 31, 2018
215.00K